Core Viewpoint - Daye Intelligent has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to a formal case being opened against the company [1][2][3]. Summary by Relevant Sections Company Announcement - On December 27, 2025, Daye Intelligent announced that it received a "Notice of Case Filing" from the CSRC, indicating that the company is under investigation for potential information disclosure violations [1][2]. Legal Implications - According to the Securities Law and related regulations, if a company fails to disclose information as required or provides false or misleading statements, it may be liable for damages incurred by investors [3]. Investor Compensation - Investors who purchased Daye Intelligent stock before December 26, 2025, and still held the shares at the close of trading on that date may be eligible to file for compensation [2][3]. - Required documentation for compensation claims includes: 1. Original transaction statements for Daye Intelligent stock, stamped by the brokerage [3]. 2. Copies of the investor's ID [4]. 3. A securities account inquiry statement from the brokerage [4].

Core Viewpoint - The company, Zhenlei Technology, is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws due to accounting errors related to revenue recognition [2][6]. Group 1: Company Overview - Zhenlei Technology specializes in terminal radio frequency front-end chips, high-density packaged microwave modules, and micro-systems, operating as a private high-tech enterprise that integrates design, development, production, and sales [1][5]. Group 2: Regulatory Investigation - On December 26, 2025, the company received a notice from the CSRC regarding an investigation into suspected information disclosure violations [2][6]. - The company disclosed on December 24, 2025, that its wholly-owned subsidiary, Hangzhou Chengxin Technology Co., Ltd., had an accounting error in 2022, where 8.4265 million yuan (approximately 1.2 million USD) of revenue (3.47% of 2022 total revenue) was recognized without sufficient basis, affecting the accuracy of financial data in reports up to the third quarter of 2025 [2][6]. Group 3: Financial Impact - The accounting error led to inaccuracies in the 2022 semi-annual report, where the erroneous revenue represented 8.04% of the semi-annual revenue of 104,846,515.85 yuan (approximately 14.8 million USD) [2][6]. Group 4: Compensation Conditions - Investors who purchased shares between August 25, 2022, and December 26, 2025, and sold or continued to hold them after December 27, 2025, are eligible for compensation [4][8].

新京报贝壳财经讯12月28日，海南葫芦娃药业集团股份有限公司(下称"ST葫芦娃（605199）")发布公告 称，公司及公司董事长刘景萍于2025年12月26日分别收到中国证券监督管理委员会下发的《立案告知 书》。因公司及公司董事长刘景萍涉嫌信息披露违法违规，根据《中华人民共和国证券法》《中华人民 共和国行政处罚法》等法律法规，中国证监会决定对公司和刘景萍立案。目前，公司各项生产经营活动 正常有序开展，在立案调查期间，公司将积极配合中国证监会的相关调查工作，并严格按照有关法律法 规及监管要求履行信息披露义务。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605199 证券简称：ST葫芦娃（维权） 公告编号：2025-092 海南葫芦娃药业集团股份有限公司 海南葫芦娃药业集团股份有限公司（以下简称"公司"）及公司董事长刘景萍女士于2025年12月26日分别 收到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》（编号：证监立案字 0292025008号和证监立案字0292025009号）。因公司及公司董事长刘景萍女士涉嫌信息披露违法违规， 根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司和 刘景萍女士立案。 目前，公司各项生产经营活动正常有序开展，在立案调查期间，公司将积极配合中国证监会的相关调查 工作，并严格按照有关法律法规及监管要求履行信息披露义务。 公司指定信息披露媒体为《上海证券报》《中国证券报》《证券日报》《证券时报》和上海证券交易所 网站（www.sse.com.cn），公司相关信息均以公司在上述指定媒体披露的信息为准。敬请广大投资者理 性投资，注意投资风险。 特此公告。 海南葫芦娃药业集团股份有限公司董事会 关于收到中国证券监督管 ...

12月28日晚，ST葫芦娃（605199.SH）公告称，公司及公司董事长刘景萍于2025年12月26日分别收到中国证监会下发的《立案告知书》。因公司及公司董事 长刘景萍涉嫌信息披露违法违规，中国证监会决定对公司和刘景萍立案。 3月14日，ST葫芦娃收到海南证监局出具的《关于对海南葫芦娃药业集团股份有限公司采取责令改正措施的决定》，决定书中指出：2023年公司部分销售业 务存在提前确认收入，部分销售业务存在销售价格异常，以及因提前确认收入产生对应费用差异，导致公司相关定期报告披露的财务数据不准确。 在2025年半年报中，ST葫芦娃表示，上半年在复杂多变的医药市场环境中，行业竞争加剧与需求调整，公司紧密围绕发展战略规划，积极应对挑战，各项 业务有序开展。公司始终坚持以儿童健康为核心，在儿童药、成人用药及营养补充剂等领域不断深耕，通过强化研发创新、优化生产运营、拓展市场渠道等 举措，努力提升企业的核心竞争力与市场影响力。 因公司2024年度内部控制被立信会计师事务所出具了否定意见的《内部控制审计报告》，4月30日，公司A股股票简称由"葫芦娃"变更为"ST葫芦娃"。 受行业竞争格局调整及市场需求阶段性变化影响，ST葫 ...

Group 1 - Aerospace Development's subsidiary, Chongqing Tianmu Satellite Technology Co., Ltd., accounted for less than 1% of the company's total revenue in the first three quarters of 2025 [2] - Aerospace Development achieved a revenue of 1.697 billion yuan in the first three quarters of 2025, an increase attributed to ship deliveries [2] - The company focuses on aerospace defense information technology, continuing to develop blue army systems and new-generation communication and command equipment [2] Group 2 - Victory Energy announced that if its stock price continues to rise, it may apply for a trading suspension for verification [3] - Jia Mei Packaging stated that its stock price has significantly deviated from its fundamentals, and it may also apply for a trading suspension if prices rise further [4] - Fenglong Co. confirmed that there are no plans to change its main business or make significant adjustments in the next 12 months [5] Group 3 - ST Huluwa announced that the company and its chairman are under investigation by the China Securities Regulatory Commission for information disclosure violations [6] - Yijing Optoelectronics is facing challenges in its photovoltaic project in Quanjiao County, with a potential investment agreement termination and a demand for repayment of 140 million yuan [7] - Tongyu Communications warned of risks related to market sentiment and irrational speculation due to significant stock price fluctuations [8] Group 4 - Junda Co. stated that its strategic cooperation agreement with Shangyi Optoelectronics will not have a significant impact on its current operating performance [9] - Heng Rui Pharmaceutical signed an exclusive licensing agreement with Hansoh Pharmaceutical, with potential milestone payments totaling up to 190 million yuan [10] - Tongye Technology plans to acquire 91.69% of Beijing Silingke Semiconductor Technology Co., Ltd. for 561 million yuan [11] Group 5 - ST Lutong intends to apply for the removal of other risk warnings after a shareholder repaid 10.2254 million yuan in funds [12] - Wangfujing won the bid for the Beijing Capital International Airport duty-free project, with a guaranteed operating fee of 113 million yuan for the first year [14]

公告中，ST葫芦娃并未披露涉嫌信息披露违法违规的具体细节。公司仅表示，目前，公司各项生产经 营活动正常有序开展，在立案调查期间，公司将积极配合中国证监会的相关调查工作。 登录新浪财经APP 搜索【信披】查看更多考评等级 面对每天上千份上市公司公告该看哪些？重大事项公告动辄几十页几百页重点是啥？公告里 一堆专业术语不知道算利好还是利空？请看智通财经公司新闻部《速读公告》栏目，我们派 驻全国的记者们将于公告当晚为您带来准确、快速、专业的解读。 智通财经12月28日讯（记者 黄路）今年以来风波不断，ST葫芦娃(605199.SH)再爆"雷声"，公司及董事 长被中国证监会立案调查。 今晚，ST葫芦娃公告，公司及董事长刘景萍于2025年12月26日分别收到中国证监会下发的《立案告知 书》（编号：证监立案字 0292025008 号和证监立案字 0292025009号）。因公司及公司董事长刘景萍涉 嫌信息披露违法违规，中国证监会决定对公司和刘景萍立案。 实际上，公司今年以来频频"爆雷"多与其财务信息披露相关。今年3月14日，ST葫芦娃收到海南证监局 出具的《关于对海南葫芦娃药业集团股份有限公司采取责令改正措施的决定》，决 ...

针对陈丹华的《行政处罚决定书》显示，2020年12月陈丹华参与智动力非公开发行股票认购后，因部分认购资金为配资方提供，后续公司股价接近平仓线且 未补充保证金，其持有的284.25万股股票于2021年10月被强行平仓，导致任职期间违规减持股份179.53万股，违规交易金额1861.35万元。深圳证监局认定其 行为违反限制性规定转让公司股票，结合其积极配合调查的情节，决定对其给予警告并处罚款80万元。 智动力表示，上述行政处罚事项仅涉及相关人员个人，与公司经营无关，不会对公司生产经营产生影响，目前公司生产经营一切正常。 12月26日，智动力发布公告，披露公司实际控制人吴加维、陈奕纯夫妇及时任副总经理陈丹华收到中国证监会深圳监管局出具的《行政处罚决定书》，三人 因分别涉及信息披露违法违规、违反限制性规定转让公司股票，合计被处以230万元罚款。 公告显示，智动力曾于2024年11月1日披露相关立案告知书，此次行政处罚系该立案调查的最终结果。其中，针对吴加维、陈奕纯的《行政处罚决定书》指 出，2020年11月14日，吴加维、陈奕纯的一致行动人吴加和、吴雄驰与深圳市远致瑞信混改股权投资基金合伙企业（有限合伙）签署《股份转 ...

Core Viewpoint - The company, Changyuan Technology Group Co., Ltd. (ST Changyuan), is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, but its operations remain unaffected as of now [2][2][2] Group 1: Investigation Details - The CSRC has issued a notice of investigation to the company on December 26, citing violations of the Securities Law of the People's Republic of China and the Administrative Penalty Law [2][2] - During the investigation, ST Changyuan will cooperate with the CSRC and adhere to legal and regulatory requirements, ensuring timely information disclosure to protect investors' rights [2][2][2] Group 2: Business Operations - ST Changyuan's main business includes smart grid equipment, energy internet technology services, consumer electronics, and lithium iron phosphate materials, with applications in the electric vehicle industry [2][2] - The subsidiary, Jinli Technology, focuses on the research, production, and sales of lithium battery cathode materials, specifically lithium iron phosphate, which is used in power, energy storage, and consumer electronics batteries [2][2] - Jinli Technology reported revenue of 47.55 million yuan in the first half of 2025, accounting for 1.37% of the company's total revenue [2][2][2] Group 3: Leadership Issues - On November 24, the company received a notice of detention regarding its chairman and legal representative, Qiao Wenjian, due to suspected job-related violations [2][2]

Core Viewpoint - The company Beilingsong (倍轻松) is under investigation by the China Securities Regulatory Commission (CSRC) for alleged violations of information disclosure laws, which has led to a significant drop in its stock price and raised concerns about its financial stability [2][3]. Company Overview - Beilingsong is a high-tech enterprise focused on the innovation, research, and development of health products, primarily engaged in the design, production, and sales of smart portable health hardware [3]. - The company has a current market capitalization of 1.943 billion yuan [2][3]. Financial Performance - For the first three quarters of 2025, Beilingsong reported a revenue of 552 million yuan, with a net profit attributable to shareholders of -29.51 million yuan in the third quarter [4]. - The company’s actual controller, Ma Xuejun, recently reduced his stake by transferring 2.97% of the total shares, raising approximately 64.71 million yuan [4]. Recent Developments - On December 25, 2025, the CSRC issued a notice of investigation to Beilingsong and its actual controller Ma Xuejun for suspected information disclosure violations [2]. - In response to the investigation, the company stated that its business operations remain normal and it will cooperate with the CSRC [2]. - Prior to the investigation notice, Ma Xuejun executed a significant share sale, contrasting with another major shareholder, Wang Qiaoqing, who decided to terminate a planned share reduction, citing confidence in the company's long-term development [4]. Capital Needs - On December 23, 2025, just two days before the investigation notice, Beilingsong announced the completion of certain fundraising projects and the decision to permanently supplement its working capital with 19.21 million yuan from the remaining funds [5].